openPR Logo
Press release

Global Autoimmune Disease Diagnostics Market to Grow with a CAGR of 8.4% from 2022-2027, Propelled by Rising Cases of Autoimmune Diseases and Increasing Awareness

01-27-2022 07:03 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Renub Research

/ PR Agency: Renub Research
The Global Autoimmune Disease Diagnostics Market is classified into North America, Europe, Asia Pacific, Middle East & Africa and

The Global Autoimmune Disease Diagnostics Market is classified into North America, Europe, Asia Pacific, Middle East & Africa and

According to Renub Research report, tittled “Autoimmune Disease Diagnostic Market, Size. Global Forecast 2021-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis” the Autoimmune Disease Diagnostics Market will be USD 8.02 Billion by 2027. Autoimmune disorders are a species of more than 80 chronic diseases, out of which multiple sclerosis, Systemic Lupus Erythematosus (SLE), rheumatoid arthritis, and type I diabetes are the most common autoimmune diseases. An autoimmune disease transfers to a condition wherein the immune system destroys and attacks healthy cells, organs of the body, and tissues. In the longer run, it can further lead to abnormal growth of an organ and changes in organ function.

As per Scientific American in 2021, several autoimmune diseases affect as much as 4.5 percent of the world's population. Further, a diagnostic of autoimmunity suspected based on a patient’s symptoms, blood test results and details of their family history. Diagnosis of an autoimmune disease includes tests to identify whether the body produces these autoantibodies. Apart from this, several governing authorities and non-governing organizations are funding various programs to develop the autoimmune disease diagnostic market.

For instance, launched by the Accelerating Medicines Partnership (AMP), the AMP RA/SLE Program is public-private (NIH) cooperation between the National Institutes of Health, the US Food and Drug Administration (FDA) and multiple non-profit organizations. The program aims to recognize relevant drug targets for diagnosing autoimmune diseases. The other determinants, such as partnerships with physici, improved laboratory automation, clinical laboratories, and technological advancements, encourage the autoimmune disease diagnostics market. Hospital professionals worldwide are focusing on adopting advanced technologies to conduct multiple tests with faster and more precise results.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=autoimmune-disease-diagnostic-market-p.php

Consistent use for Systemic and Localized Diseases

Localized autoimmune disease diagnostics segment is further bifurcated into type 1 diabetes, multiple sclerosis, idiopathic thrombocytopenic purpura, Hashimoto's thyroiditis, and others. The rising incidence of localized autoimmune diseases such as type 1 diabetes, and multiple sclerosis; and growing patient awareness for getting tested for these diseases opt diagnostics. This can be owed to the improved adoption of diagnostics kits and assays with consumers' recurring incidences of autoimmune disorders.

Similarly, systemic autoimmune disease diagnostics is characterized into rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE), and others. Systemic autoimmune diseases are a large and clinically diverse cluster of disorders. They share in common inappropriate targeting of healthy tissues by immune and inflammatory mechanisms leading to self-injury. With technical developments in multiple autoantibodies screening tests to assist in the early diagnosis and treatment of systemic autoimmune diseases.

Worldwide Autoimmune Disease Diagnostics Market Size was US$ 4.94 Billion in 2021

Based on Disease, autoimmune disease diagnostics market includes systemic Lupus Erythematosus, Thyroiditis, Rheumatoid Arthritis, Sjögren’s Syndrome, Scleroderma and Others. Rheumatoid arthritis disease mainly attacks the synovial tissues within the joints. The disease predominantly affects aging patients. The old population coupled with technological advancements in immunofluorescence and proteomics technologies has intensified the rheumatoid arthritis diagnosis. Off-label prescription of NSAIDs, growing incidence of autoimmune diseases, and other pain management drugs boost the demand for rheumatoid arthritis diagnosis.

Moreover, thyroiditis is also known as Hashimoto's disease, thyroid-stimulating hormone test, anti-thyroid antibodies test, and free T4 test are the primary tests for Hashimoto's thyroiditis. Heart problems, myxedema, and goiter and mental health issues are the significant complications of thyroiditis. The rising prevalence of thyroiditis diseases has significantly impacted the autoimmune disease diagnostics industry.

Regional Analysis of Autoimmune Disease Diagnostics Industry

Regionally, European countries have an enormous demand for autoimmune disease diagnosis due to the increasing most autoimmune disorders. As per Ms Barometer, in 2020, 1 million people lived with multiple sclerosis (MS) in Europe, and the prevalence rate of multiple sclerosis is increasing, especially in women than men. Besides, the increasing awareness of auto-immune diseases, through education, support, research, and advocacy is a crucial part augmenting the usage rates. The European Commission is taking several moves to increase awareness among the public regarding the risk factors in improving autoimmune diseases. Consequently, as symptoms occur, they seek diagnosis and begin a treatment regimen.

Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/autoimmune-disease-diagnostic-market-p.php

Impact of COVID-19 on Autoimmune Disease Diagnostics

Worldwide, the patients undergoing from autoimmune disease feared the COVID-19 had severe adverse reactions or that the autoimmune disease may worsen amidst the pandemic. So, certain patients could be at a higher risk of severe COVID-19. Therefore, the health providers working consistently for the patients served regular autoimmune disease diagnoses, thus helping the growth of the diagnostic market. The leading players in the global autoimmune disease diagnostics market are Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers, and bioMerieux SA.

Market Summary:

Type – We have covered Market breakup by 2 viewpoints by-type (Systemic Autoimmune Disease Diagnostics and Localized Autoimmune Disease Diagnostics)
Disease – Renub Research Report covered by Disease in the 6 viewpoints (Systemic Lupus Erythematosus, Thyroiditis, Rheumatoid Arthritis, Sjögren’s Syndrome, Scleroderma and Others)
End Users – Our Report covers by End Users in the 3 viewpoints (Hospitals, Clinical Laboratories and Others)
Region – This Report covers Autoimmune Disease Diagnostic Market breakup by 5 Region (North America, Europe, Asia-Pacific’s, Latin America and Middle East & Africa)
All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Revenue Analysis) Abbott Laboratories, Bio-Rad Laboratories, Roche Diagnostics, Siemens Healthineers and bioMerieux SA

Browse Related Report:

Microcarrier Market: https://www.renub.com/microcarrier-market-p.php

Lung Cancer Screening Market: https://www.renub.com/lung-cancer-screening-market-p.php

Drug Abuse Testing Market: https://www.renub.com/drugs-abuse-testing-market-p.php

Point of Care Diagnostic Market: https://www.renub.com/point-of-care-diagnostic-market-p.php

Europe Veterinary Healthcare Market: https://www.renub.com/europe-veterinary-healthcare-market-p.php

United States and Canada Cervical Cancer Screening Market: https://www.renub.com/united-states-and-canada-cervical-cancer-screening-market-p.php

Lung Cancer Diagnostics Market: https://www.renub.com/lung-cancer-diagnostics-market-p.php

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food & Beverages, Power & Energy, Information Technology, Telecom & Internet, Chemical, Logistics & Automotive, Consumer Goods & Retail, Building, and Construction, & Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.

Contact Us:
Renub Research
Phone No: +1 678-302-0700 (USA) | +91–120–421–9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research
Follow on Twitter: @renubresearch

Roswell, GA 30076

Our research helps to make business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them with findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis, and forecasting that is essential in today's ultra-competitive markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Autoimmune Disease Diagnostics Market to Grow with a CAGR of 8.4% from 2022-2027, Propelled by Rising Cases of Autoimmune Diseases and Increasing Awareness here

News-ID: 2538680 • Views:

More Releases from Renub Research

Autoimmune Disease Diagnostics Market Hits US$5.32 Billion in 2023, Anticipated to Surge at 7.17% CAGR from 2024 to 2030 ⅼ Renub Research
Autoimmune Disease Diagnostics Market Hits US$5.32 Billion in 2023, Anticipated …
Global Autoimmune Disease Diagnostics market is projected to be valued at around US$ 8.64 Billion by 2030, as per Renub Research. Autoimmune disease diagnostics normally contain a combination of blood markers, specific signs, and sometimes a tissue biopsy. Autoimmune disorders broaden whilst the immune device attacks its cells due to abnormalities. The failure to detect immune cells, tissues, & organs and produce autoantibodies targeting these cells reasons the immune system
Global Automotive Actuators Market on Track to Reach US$ 40.93 Billion by 2030 ⅼ Forecast (2024 - 2030) ⅼ Renub Research
Global Automotive Actuators Market on Track to Reach US$ 40.93 Billion by 2030 …
Renub Research has released a report titled "Global Automotive Actuators Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2030," which includes market percentage records and a thorough enterprise analysis. This report examines the Global Automotive Actuators Market's competition, geographic distribution, and growth potential. Global Automotive Actuators Market is predicted to extend at a CAGR of 6.71% from 2024 to 2030. Automotive actuators are pivotal in the vehicle enterprise, serving as
Digital payment market size was valued at USD 3.53 trillion in 2018 and is projected to reach USD 19.89 trillion by 2026 at CAGR of 24.4% ⅼ Renub Research
Digital payment market size was valued at USD 3.53 trillion in 2018 and is proje …
Digital payment means dealings completed through digital or online mediums. It means doing the transactions through electronic medium like laptops, pads, smartphones etc. The online payment system has evolved through the time. Many new payment systems have been introduced in the years such as swapping of credit or debit cards on POS machines, scanning QR codes, NFC cards etc. Besides the rising internet penetration is expanding the digital payment market
China Baby Food Market, Size, Share, Company Analysis, Industry Trends ⅼ Forecast (2024 2030)
China Baby Food Market, Size, Share, Company Analysis, Industry Trends ⅼ Forec …
The recently released report, "China Baby Food Market: Industry Trends, Growth, Share, Size, Opportunity, and Forecast 2024-2030," produced by Renub Research, includes extensive enterprise analysis and market percentage records. The competition, geographic distribution, and growth potential of the China Baby Food Market are all examined in this study. Read More: https://www.renub.com/china-baby-food-market-p.php China Baby Food Market is predicted to extend at a CAGR of 7.00% from 2024 to 2030. The China baby food

All 5 Releases


More Releases for Disease

Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and